Pieris Pharmaceuticals, Inc.

  • Home
  • About
  • Platform
  • Pipeline
  • Patients
  • Investors
    • Overview
    • News & Events
    • Publications
    • Presentations
    • Financial Results
    • Stock Data
    • SEC Filings
    • Governance
  • Careers
    • Job Openings
  • Contact
  • News & Events

  • Overview
  • Press Releases
  • Media
  • IR Calendar
  • Email Alerts
Jan 29, 2018 8:30am EST

Pieris Pharmaceuticals to Host Key Opinion Leader Event on February 6th

Dec 07, 2017 8:30am EST

Pieris Pharmaceuticals Announces Ethics and Regulatory Clearance to Begin Clinical Testing of Inhaled Respiratory Program, PRS-060/AZD1402

Nov 21, 2017 8:30am EST

Pieris Pharmaceuticals Appoints James Geraghty as Chairman of the Board of Directors

Nov 08, 2017 4:30pm EST

Pieris Pharmaceuticals Reports Financial Results for the Third Quarter Ended September 30, 2017, and Provides Corporate Update

Nov 02, 2017 8:00am EDT

Pieris Pharmaceuticals to Host Third Quarter 2017 Investor Call and Corporate Update on November 9, 2017

Nov 01, 2017 8:00am EDT

Pieris Pharmaceuticals to Present at Investor Conferences in November

Oct 12, 2017 8:00am EDT

Pieris Pharmaceuticals Appoints Ingmar Bruns, M.D., Ph.D., as Vice President of Clinical Development

Oct 02, 2017 8:00am EDT

Pieris Pharmaceuticals Announces Dosing of First Patient in Phase I Trial for Fully Proprietary Lead IO Program, PRS-343

Sep 26, 2017 8:00am EDT

Pieris Pharmaceuticals to Present at the LEERINK Partners Roundtable Series on Thursday, September 28 at 9:30 AM ET

Aug 10, 2017 8:00am EDT

Pieris Pharmaceuticals Appoints Allan Reine, M.D., as Chief Financial Officer

  • Previous
  • 1…
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • …25
  • Next
RSS
  • Email Alerts
  • Contacts
  • RSS News Feed
© 2023 Pieris Pharmaceuticals, Inc. All Rights Reserved.
Imprint Privacy Policy Disclaimer Sitemap Contact Us Manage Cookie Preferences